Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;24(7):825-833.
doi: 10.1007/s11912-022-01257-5. Epub 2022 Mar 22.

Treatment of Metastatic Melanoma in the Elderly

Rino S Seedor  1 , Marlana Orloff  2
Affiliations
Review

Treatment of Metastatic Melanoma in the Elderly

Rino S Seedor et al. Curr Oncol Rep. 2022 Jul.

Abstract

Purpose of review: This study aims to review the clinical experience of melanoma treatments in patients with advanced age.

Recent findings: During the last decade, the treatment paradigm for melanoma has changed dramatically with the use of checkpoint inhibitors, oncolytic viruses, and targeted therapies. We reviewed both the clinical trial and real-world experience of these therapies in patients of advanced age, and discuss how a personalized approach should be taken for these patients with consideration of incidence and management of side effects. Although special consideration should be taken, immunotherapy, oncolytic viruses, and targeted therapy have shown efficacy and tolerability in older patients with melanoma.

Keywords: Checkpoint inhibitors; Elderly; Immunotherapy; Melanoma; Oncolytic virus; Targeted therapy.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Howlander N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer statistics review, 1975-2018, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2018/ , based on November 2020 SEER data submission, posted to the SEER Web site, April 2021.
    1. Bhatt VR, Shrestha R, Krishnamurthy J, Mosalpuria K, Loberiza FR, Ganti AK, et al. Clinicopathologic characteristics and management trends of cutaneous invasive and in situ melanoma in older patients: a retrospective analysis of the National Cancer Data Base. Ther Adv Med Oncol. 2015;7(1):4–11. - PubMed - PMC - DOI
    1. Rogiers A, van den Oord JJ, Garmyn M, Stas M, Kenis C, Wildiers H, et al. Novel therapies for metastatic melanoma: an update on their use in older patients. Drugs Aging. 2015;32(10):821–34. - PubMed - DOI
    1. Bastiaannet E, Battisti N, Loh KP, de Glas N, Soto-Perez-de-Celis E, Baldini C, et al. Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper. J Geriatr Oncol. 2019;10(3):389–97. - PubMed - DOI
    1. Iacono D, Vitale MG, Basile D, Pelizzari G, Cinausero M, Poletto E, et al. Immunotherapy for older patients with melanoma: from darkness to light? Pigment Cell Melanoma Res. 2021;34(3):550–63. - PubMed - DOI

LinkOut - more resources